Encapsulation of pancreatic cells derived from human pluripotent stem cells

• US 9,132,226 B2
• Filed: 05/24/2013
• Issued: 09/15/2015
• Est. Priority Date: 11/14/2008
• Status: Active Grant

• Current Assignee: Viacyte Incorporated (Vertex Pharmaceuticals Incorporated)
• Original Assignee: Viacyte Incorporated (Vertex Pharmaceuticals Incorporated)
• Inventors: Martinson, Laura, Green, Chad, Kroon, Evert, Baetge, Emmanuel Edward
• Primary Examiner(s): Chen, Shin Lin
• Application Number:
  US13/902,774
• Publication Number:
  US 20130261568A1
• Time in Patent Office: 844 Days
• Field of Search: 424/422, 424/423, 424/424, 604/502
• US Class Current: 1/1
• CPC Class Codes: A01N 1/0221 Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
• CPC Class Codes: A61F 2/022 Artificial gland structures using bioreactors hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36
• CPC Class Codes: A61K 2035/126 Immunoprotecting barriers, e.g. jackets, diffusion chambers
• CPC Class Codes: A61K 35/39 Pancreas; Islets of Langerhans Langerhans cells of epidermis A61K35/36
• CPC Class Codes: A61K 38/28 Insulins
• CPC Class Codes: A61L 2300/252 Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
• CPC Class Codes: A61L 2300/62 Encapsulated active agents, e.g. emulsified droplets
• CPC Class Codes: A61L 2300/64 Animal cells
• CPC Class Codes: A61L 27/14 Macromolecular materials
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: A61L 27/56 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61M 2202/07 Proteins
• CPC Class Codes: A61M 2205/04 implanted
• CPC Class Codes: A61M 31/00 Devices for introducing or retaining media, e.g. remedies, in cavities of the body A61M25/00 takes precedence ; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50
• CPC Class Codes: A61M 5/00 Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests vaccination appliances for veterinary use A61D1/025 ; tube connectors, tube couplings, valves or branch units specially adapted for medical use A61M39/00; containers specially adapted for medical or pharmaceutical purposes A61J1/00; combinations of vial and syringe for mixing or transferring their contents A61J1/20; holders for containers for collecting, storing or administering blood or medical fluids A61J1/16
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics
• CPC Class Codes: A61P 5/50 for increasing or potentiating the activity of insulin
• CPC Class Codes: C12N 2501/115 : Basic fibroblast growth factor (bFGF, FGF-2)
• CPC Class Codes: C12N 2501/117 : Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
• CPC Class Codes: C12N 2501/119 : Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
• CPC Class Codes: C12N 2501/16 : Activin; Inhibin; Mullerian inhibiting substance
• CPC Class Codes: C12N 2501/19 : Growth and differentiation factors [GDF]
• CPC Class Codes: C12N 2501/385 : of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
• CPC Class Codes: C12N 2501/41 : Hedgehog proteins; Cyclopamine (inhibitor)
• CPC Class Codes: C12N 2501/415 : Wnt; Frizzeled
• CPC Class Codes: C12N 2506/02 : from embryonic cells
• CPC Class Codes: C12N 5/0676 : Pancreatic cells
• CPC Class Codes: C12N 5/0678 : Stem cells; Progenitor cells; Precursor cells

Abstract

The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.

Claims

1. A device comprising:

a first cell encapsulation chamber having a lumen; and

a second cell encapsulation chamber having a lumen, wherein said first and second cell encapsulation chambers are sealed at the peripheral edges, wherein said first and second cell encapsulation chambers are separated by at least one separation seal, and wherein the at least one separation seal does not cause an increase in the surface area of the device.

2. The device of claim 1, wherein each cell encapsulation chamber has at least one port.

3. The device of claim 1, wherein each cell encapsulation chamber has two ports.

4. The device of claim 1, wherein the separation seal intersects with the sealed edge.

5. The device of claim 1, wherein the first cell encapsulation chamber is completely sealed from the second cell encapsulation chamber.

6. The device of claim 1 further comprising living cells.

7. The device of claim 6, wherein the living cells comprise human pancreatic and duodenal homeobox gene 1 (PDX1)-positive pancreatic progenitor cells.

8. The device of claim 1, wherein the separation seal limits the lumen thickness of the cell encapsulation chambers.

9. The device of claim 1, wherein the first and second cell encapsulation chambers comprise a semi-permeable membrane.

10. A cell encapsulating assembly, said assembly comprising a plurality of chambers, each having a lumen comprising living cells, wherein the assembly comprises a first seal at a peripheral edge of the assembly, thereby forming the cell encapsulating assembly, and at least a second seal, wherein said second seal is within said cell encapsulating assembly, thereby sealing off the cell encapsulation chambers from one another, wherein the living cells comprise human pancreatic and duodenal homeobox gene 1 (PDX1)-positive pancreatic progenitor cells.

11. The assembly of claim 10, wherein each cell encapsulation chamber has at least one port.

12. The assembly of claim 10, wherein each cell encapsulation chamber has two ports.

13. The assembly of claim 10, wherein the second seal intersects with the first seal at the peripheral edge.

14. The assembly of claim 10, wherein each of the cell encapsulation chambers in the assembly is completely sealed off from one another.

15. The assembly of claim 10, wherein the second seal limits the lumen thickness of the cell encapsulation chambers.

16. The assembly of claim 10, wherein the plurality of cell encapsulation chambers comprise a semi-permeable membrane.